about
Levels of soluble E-cadherin in breast, gastric, and colorectal cancersHepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemiaAngiogenesis Inhibitors for the Treatment of Hepatocellular CarcinomaElevated B cell-activating factor of the tumour necrosis factor family in coeliac diseaseType II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation.Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells.MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer.Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancerIdentification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.Latent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma.Evaluation of the suitability of archival Bouin-fixed paraffin-embedded tissue specimens to proteomic investigation.Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules.T cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.Hepatitis C virus, B-cell proliferation and lymphomas.Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.Differential proteomics of Helicobacter pylori associated with autoimmune atrophic gastritisGenetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.Second primary lymphoma or recurrence: a dilemma solved by VDJ rearrangement analysis.Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.Hepatitis C virus infection, cryoglobulinaemia, and beyond.The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies.Recent patents relating to HCV molecules like putative targets for therapeutic intervention.Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature.Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia?Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies.The versatile role of gliadin peptides in celiac disease.Cancer treatment and the KIR-HLA system: an overview.IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.New Insights into the Pathogenesis of Celiac Disease.Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus.Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection.Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas.Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders.
P50
Q27012638-8B486F63-A88C-4074-AD21-85EEE1711CAAQ27478141-A7C727D8-7B47-409E-AFA1-655ECC8CF7E0Q28075305-65D6BAF8-2EA8-4974-A589-762CC8644E4EQ28248398-25FB9E2B-FF09-4D5C-85F1-743C75C6A7D9Q30806356-C58F1F28-65B2-4106-AA7A-8B01CC8973A9Q33225377-CFC6B3B8-0BB1-46C6-BA20-9F6E9109274BQ33276657-B25301F6-8CFE-4520-856A-AC1E36F66C12Q33579778-717EBAE9-FA28-4055-8394-E221339106B6Q33612957-35CC0C31-2DA1-46E7-A3AD-5C6E17FA62BAQ33709692-70BDA1AC-D7E8-4046-B036-769CB58D1F17Q33780975-ADCBC28E-4152-40BF-B341-93556CE53D5AQ34287040-F0A53D61-0C99-41C1-A04D-1BCD51DC2E68Q34510721-42DCED3F-F8DB-4BDC-8FFA-42DF114CF5CFQ34545880-0AED9E0C-4C68-478B-8592-617A16557BD1Q34662450-3408085A-D90B-4449-A973-D4E5823E837BQ34769865-2A2F5B1E-B80C-4D8A-BC07-730B14D4CB8EQ35034978-3DAEA0B8-7EA9-4553-93C7-0B3F9580AE2EQ35084203-C137044F-A23C-4AB1-8BBE-ADFE572E6B95Q35107234-77BD68BF-1F75-46E6-94BC-BDA208482286Q35888674-827A94B5-0C2C-4FE3-BB90-69EA0DBC6204Q36117230-082B2E03-B9A5-435D-870C-11DDDE2EBCF9Q36743421-9325B5E1-F90C-4F0C-9100-8EEDF428EE21Q36760218-82B67A1C-A594-4CA6-A326-30C5D945C38CQ37330181-C996A7B4-0A96-4479-A1C4-55F84E29EEE9Q37347951-746D12DE-CDE1-403E-A90E-81806FE2B629Q37475341-5BD0EA30-9960-4B16-862D-887D7E449A59Q37537926-A977211A-F757-4FD6-9EA1-4261892A5E34Q37739271-17979C9B-3112-4B26-9B47-AC173A419C19Q37772795-8BD43017-DA08-4209-A9AE-96F210B29B4FQ38059073-E1AB9534-159B-4D1A-B375-1EEB81AD12B9Q39131056-95DE926B-7203-4199-BD10-3A61E5248BFFQ39329992-DDEE7E7E-15D4-4C50-8F83-C0584BD6F00CQ40605162-6CD38824-37B9-4D76-B0C5-310DBE258E14Q41605556-C7D1F795-9742-4471-9575-D550D3EF0B79Q42133572-DA274D77-2C13-451F-95E5-9C2026C2C523Q42552269-61478994-75E4-4D3F-BFB6-40FFF92A861BQ42634416-0809A858-F0DD-4EF5-8D65-C79F40EFC58FQ42983323-BA681415-F231-4BF1-BAB9-05FB4CD85EB7Q42985596-8E4C3708-CBB4-4F5D-89DA-091A6BC6D6FFQ42995372-6AD6B5B8-5B4C-4D5A-9DA9-E7BB64BC20D6
P50
description
researcher
@en
wetenschapper
@nl
name
V De Re
@ast
V De Re
@en
V De Re
@nl
type
label
V De Re
@ast
V De Re
@en
V De Re
@nl
prefLabel
V De Re
@ast
V De Re
@en
V De Re
@nl
P106
P31
P496
0000-0001-6100-9373